NCT01286701View on ClinicalTrials.gov

Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy's Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

February 28, 2002

Study Completion Date

March 31, 2002

Conditions
Healthy
Interventions
DRUG

Terbinafine Hydrochloride Tablets, 250 mg

Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy's Laboratories Limited.

Trial Locations (1)

GIV 2K8

Anapharm Inc., Québec

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY